Skip to content
FDA Approves New Drug for Relapsing MS
avatar
Elizabeth_WebMD_Staff posted:
In a two-year study, the Aubagio reduced yearly relapses by nearly a third compared to placebo and also slowed the progression of the disease. This new med will be prescribed for relapsing forms of MS.

FDA Approves New MS Drug Aubagio

For more info about the study see this information from the National Multiple Sclerosis Society.

Will you be talking with your doctor about this?

Elizabeth
Reply


Featuring Experts

Neil S. Lava, MD, is the director of the multiple sclerosis clinic at Emory University in Atlanta. He has been treating multiple sclerosis patients si...More

Helpful Tips

Help Our Community & Experts Help You - Please Read
Welcome to the WebMD Multiple Sclerosis Community! Please don't respond to this discussion. Instead, please read before you start your ... More
Was this Helpful?
106 of 108 found this helpful

Related News

There was an error with this newsfeed

Related Drug Reviews

  • Drug Name User Reviews

Report Problems With Your Medications to the FDA

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.